3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
272
Leukemia
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
131
Lymphoma
108
Congenital Abnormalities
68
Myelodysplastic Syndromes
63
Leukemia, Myelomonocytic, Acute
60
Leukemia, Monocytic, Acute
58
Leukemia, Erythroblastic, Acute
56
Leukemia, Megakaryoblastic, Acute
54
Lymphoma, Non-Hodgkin
51
Burkitt Lymphoma
44
Lymphoma, Mantle-Cell
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Follicular
33
Leukemia, Myelomonocytic, Chronic
28
Anemia, Refractory, with Excess of Blasts
27
Hodgkin Disease
26
Recurrence
25
Lymphoma, Large-Cell, Immunoblastic
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Blast Crisis
24
Leukemia, Eosinophilic, Acute
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Myeloproliferative Disorders
17
Leukemia, Basophilic, Acute
17
Lymphoma, B-Cell, Marginal Zone
16
Leukemia, Promyelocytic, Acute
16
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Accelerated Phase
14
Interventions
Doxorubicin
11
Razoxane
5
Dexrazoxane
5
Electrocardiography
4
Echocardiography
4
Cyclophosphamide
4
Vincristine
3
Trastuzumab
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Exercise
3
Etoposide
3
Carvedilol
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
Bleomycin
2
salicylhydroxamic acid
1
oblimersen
1
hydrocortisone hemisuccinate
1
dapagliflozin
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Tablets
1
Silymarin
1
Reverse Transcriptase Polymerase Chain Reaction
1
Resistance Training
1
Pulse Wave Analysis
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiotoxicity
×
Cytarabine
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled